Balyasny Asset Management L.P.
Position in TAK — Takeda Pharmaceutical Co Ltd
CIK 1218710
Chicago, IL
Position in TAK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,603,504
+$404,940 QoQ
Shares Held
140,578
-0.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
12 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Balyasny Asset Management L.P. holds $180,059,722 across 19 Drug Manufacturers - Specialty & Generic names. TAK ranks #10 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
539,382 | $40,912,124 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
499,792 | $24,064,984 | |
| 3 | BIOA |
BioAge Labs, Inc.
|
1,327,545 | $23,218,762 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
36,623 | $21,716,706 | |
| 5 | ALKS |
Alkermes plc.
|
586,775 | $20,748,363 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
1,107,271 | $15,391,066 | |
| 7 | AQST |
Aquestive Therapeutics, Inc.
|
2,900,570 | $12,037,365 | |
| 8 | PRGO |
PERRIGO Co plc
|
804,856 | $8,644,153 |
All Filings in TAK
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,603,504 | 140,578 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,198,564 | 141,024 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $188,874 | 12,217 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $175,064 | 11,773 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,558,007 | 193,203 | Shares | Sole | 2025-02-14 | |
| 2024-03-31 | $213,267 | 15,354 | Shares | Sole | 2024-05-13 | |
| 2023-09-30 | $324,978 | 21,007 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $523,849 | 33,345 | Shares | Sole | 2023-08-14 | |
| 2022-09-30 | $733,090 | 56,522 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $208,297 | 14,836 | Shares | Sole | 2022-08-15 | |
| 2021-06-30 | $987,533 | 58,677 | Shares | Sole | 2021-08-16 | |
| 2020-03-31 | $240,511 | 15,844 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||